Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this study is to test a novel nurse-delivered patient navigation program for women with HER2+ metastatic breast cancer (mBC) receiving tucatinib, trastuzumab, and capecitabine. The program will focus on enhancing understanding of the treatment regimen, managing symptoms and adherence, and improving coping and self-management skills. If successful, the program could be integrated into clinical care to better support mBC patients. The main question the study aims to answer is: is the patient navigation program feasible and acceptable for mBC patients? Participants will receive patient navigation sessions over about 6 weeks. Participants will also complete study assessments via electronic survey at baseline and at about 3 and 6 weeks after enrollment, with the last assessment occurring after completion of the patient navigation program sessions. Participants will also complete a post-program exit interview.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Kobieta (z przypisaną płcią żeńską przy urodzeniu)
- •Wiek co najmniej 18 lat
- •Diagnoza zaawansowanego raka piersi HER2+
- •Leczenie tucatinibem w połączeniu z kapecytabiną i trastuzumabem
- •Umiejętność mówienia i czytania w języku angielskim
✗ Disqualifies
- •Poważne problemy ze wzrokiem lub słuchem
- •Poważne zaburzenia poznawcze
- •Poważna choroba psychiczna uniemożliwiająca uczestnictwo
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 8, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Duke Cancer Institute
Durham, United States
Trial contact
Smrithi Divakaran, MPH
Michael W Willis
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/9/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.